Hepastrong AMINO protects liver from fat accumulation. Ornithine cleans liver from toxic ammonia. Lowers ALT, AST. Prevents inflammation.

FATTY LIVER IS VERY COMMON

Newest 2022 study shows us that:

  • Men have approximately 2x higher incidence of fatty liver than women

  • Men exhibit increased visceral fat deposition, lack estrogen receptors, and tend to synthesize fatty acids into fat storage
  • But development of fatty liver is faster in post menopausal women, because of rapid estrogen decrease

Reference: Chen XY, et al. Nonalcoholic fatty liver disease shows significant sex dimorphism. World J Clin Cases, 2022

Hepastrong AMINO protects liver from fat accumulation. Ornithine cleans liver from toxic ammonia. Lowers ALT, AST. Prevents inflammation.

Steatosis or non-alcoholic fatty liver disease

Non-alcoholic fatty liver disease (NAFLD) is one of the most common chronic liver diseases in the World

  • About 25% of total community have fatty liver

  • 65% people with type 2 diabetes have fatty liver

  • 8 out of 10 obese people have fatty liver

Hepastrong AMINO protects liver from fat accumulation. Ornithine cleans liver from toxic ammonia. Lowers ALT, AST. Prevents inflammation.

FATTY LIVER DISEASE IS REVERSIBLE

Fatty liver disease occurs when excess fat builds up in the liver cells. If the disease is not treated, it will progress to cirrhosis, which cannot be cured.

Reasons for fat accumulation:

  • Unhealthy lifestyle (fatty food)
  • Medication
  • Chronic diseases (diabetes)
  • Genetics

Start treatment on time to prevent irreversible damage

About treatment
Hepastrong AMINO protects liver from fat accumulation. Ornithine cleans liver from toxic ammonia. Lowers ALT, AST. Prevents inflammation.

DIAGNOSTIC TESTS FOR LIVER DISEASE

Fatty liver disease is usually diagnosed on the basis of ultrasound and blood tests, which may show elevated levels of the liver enzymes alanine aminotransferase (ALAT) and aspartate aminotransferase (ASAT).

Elevated liver enzymes are a sign that inflammation or damage could be in the liver.

Hepastrong AMINO for fatty liver

New generation hepatoprotector

Hepastrong AMINO capsules have clinically proven efficacy in hepatoprotection– it prevents fat accumulation, ensures toxic substance excretion, regenerates cell membrane and reduces inflammation. 

Hepastrong AMINO capsules lower liver enzymes – only 1 capsule per day lowers AST and ALT enzymes and ensures detoxification.

Read more

Solé Pharma® Healthcare

Address

Plieņciema street 16, Mārupe, Latvia, LV 2167

E-mail

export@solepharm.com

Phone

+371 29484403

Solé Pharma® Healthcare

One of the leading pharmaceutical manufacturers in the Baltic States with over 50 successful trademarks worldwide. The modern production of Solé Pharma® is located in Latvia. The production is GMP certified and the production process is regulated in accordance with the directives under European Union.

GMP certified

ISO certified

EU certified

Contact Solé Pharma